{"id":"https://openalex.org/W2803445534","doi":"https://doi.org/10.4088/jcp.17m12058","title":"A Randomized, Placebo-Controlled Study of the Efficacy and Safety of Fixed-Dose Brexpiprazole 2 mg/d as Adjunctive Treatment of Adults With Major Depressive Disorder","display_name":"A Randomized, Placebo-Controlled Study of the Efficacy and Safety of Fixed-Dose Brexpiprazole 2 mg/d as Adjunctive Treatment of Adults With Major Depressive Disorder","alternate_titles":[],"publication_year":2018,"publication_date":"2018-05-22","ids":{"openalex":"https://openalex.org/W2803445534","doi":"https://doi.org/10.4088/jcp.17m12058","mag":"2803445534","pmid":"https://pubmed.ncbi.nlm.nih.gov/29873953"},"language":"en","primary_location":{"id":"doi:10.4088/jcp.17m12058","doi":"https://doi.org/10.4088/jcp.17m12058","is_oa":false,"landing_page_url":"https://doi.org/10.4088/jcp.17m12058","pdf_url":null,"source":{"id":"https://openalex.org/S17992710","display_name":"The Journal of Clinical Psychiatry","issn_l":"0160-6689","issn":["0160-6689","1534-8628","1555-2101"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4322614534","host_organization_name":"Physicians Postgraduate Press, Inc.","host_organization_lineage":["https://openalex.org/P4322614534"],"host_organization_lineage_names":["Physicians Postgraduate Press, Inc."],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Psychiatry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2803445534"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110533970","display_name":"Mary Hobart","orcid":"https://orcid.org/0009-0006-0216-1483","observed_orcids":["https://orcid.org/0009-0006-0216-1483"]},"institutions":[{"id":"https://openalex.org/I4210086062","display_name":"Otsuka (United States)","ror":"https://ror.org/00ew4na22","country_code":"US","type":"company","lineage":["https://openalex.org/I114030911","https://openalex.org/I4210086062"]},{"id":"https://openalex.org/I4405268153","display_name":"Otsuka Pharmaceutical Development & Commercialization, Inc. (United States)","ror":"https://ror.org/001nxvg84","country_code":"US","type":"company","lineage":["https://openalex.org/I4405268153"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Mary Hobart","raw_affiliation_strings":["Otsuka Pharmaceutical Development & Commercialization Inc., 508 Carnegie Center Drive, 1 University Sq Drive, Princeton, NJ 08540. Mary.Hobart@otsuka-us.com","Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Otsuka Pharmaceutical Development & Commercialization Inc., 508 Carnegie Center Drive, 1 University Sq Drive, Princeton, NJ 08540. Mary.Hobart@otsuka-us.com","institution_ids":["https://openalex.org/I4210086062","https://openalex.org/I4405268153"]},{"raw_affiliation_string":"Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, New Jersey, USA","institution_ids":["https://openalex.org/I4210086062","https://openalex.org/I4405268153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021739236","display_name":"Aleksandar Skuban","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086062","display_name":"Otsuka (United States)","ror":"https://ror.org/00ew4na22","country_code":"US","type":"company","lineage":["https://openalex.org/I114030911","https://openalex.org/I4210086062"]},{"id":"https://openalex.org/I4405268153","display_name":"Otsuka Pharmaceutical Development & Commercialization, Inc. (United States)","ror":"https://ror.org/001nxvg84","country_code":"US","type":"company","lineage":["https://openalex.org/I4405268153"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Aleksandar Skuban","raw_affiliation_strings":["Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, New Jersey, USA","institution_ids":["https://openalex.org/I4210086062","https://openalex.org/I4405268153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005720083","display_name":"Peter G. Y. Zhang","orcid":"https://orcid.org/0000-0003-0557-3572","observed_orcids":["https://orcid.org/0000-0003-0557-3572"]},"institutions":[{"id":"https://openalex.org/I4210086062","display_name":"Otsuka (United States)","ror":"https://ror.org/00ew4na22","country_code":"US","type":"company","lineage":["https://openalex.org/I114030911","https://openalex.org/I4210086062"]},{"id":"https://openalex.org/I4405268153","display_name":"Otsuka Pharmaceutical Development & Commercialization, Inc. (United States)","ror":"https://ror.org/001nxvg84","country_code":"US","type":"company","lineage":["https://openalex.org/I4405268153"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Peter Zhang","raw_affiliation_strings":["Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, New Jersey, USA","institution_ids":["https://openalex.org/I4210086062","https://openalex.org/I4405268153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075893378","display_name":"Carole Augustine","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086062","display_name":"Otsuka (United States)","ror":"https://ror.org/00ew4na22","country_code":"US","type":"company","lineage":["https://openalex.org/I114030911","https://openalex.org/I4210086062"]},{"id":"https://openalex.org/I4405268153","display_name":"Otsuka Pharmaceutical Development & Commercialization, Inc. (United States)","ror":"https://ror.org/001nxvg84","country_code":"US","type":"company","lineage":["https://openalex.org/I4405268153"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Carole Augustine","raw_affiliation_strings":["Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, New Jersey, USA","institution_ids":["https://openalex.org/I4210086062","https://openalex.org/I4405268153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033150501","display_name":"Claudette Brewer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086062","display_name":"Otsuka (United States)","ror":"https://ror.org/00ew4na22","country_code":"US","type":"company","lineage":["https://openalex.org/I114030911","https://openalex.org/I4210086062"]},{"id":"https://openalex.org/I4405268153","display_name":"Otsuka Pharmaceutical Development & Commercialization, Inc. (United States)","ror":"https://ror.org/001nxvg84","country_code":"US","type":"company","lineage":["https://openalex.org/I4405268153"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Claudette Brewer","raw_affiliation_strings":["Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, New Jersey, USA","institution_ids":["https://openalex.org/I4210086062","https://openalex.org/I4405268153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023091059","display_name":"Nanco Hefting","orcid":"https://orcid.org/0000-0003-3310-3439","observed_orcids":["https://orcid.org/0000-0003-3310-3439"]},"institutions":[{"id":"https://openalex.org/I133593841","display_name":"Lundbeck (Denmark)","ror":"https://ror.org/0564cd633","country_code":"DK","type":"company","lineage":["https://openalex.org/I133593841"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Nanco Hefting","raw_affiliation_strings":["H. Lundbeck A/S, Valby, Copenhagen, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lundbeck A/S, Valby, Copenhagen, Denmark","institution_ids":["https://openalex.org/I133593841"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045081626","display_name":"Raymond Sanchez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086062","display_name":"Otsuka (United States)","ror":"https://ror.org/00ew4na22","country_code":"US","type":"company","lineage":["https://openalex.org/I114030911","https://openalex.org/I4210086062"]},{"id":"https://openalex.org/I4405268153","display_name":"Otsuka Pharmaceutical Development & Commercialization, Inc. (United States)","ror":"https://ror.org/001nxvg84","country_code":"US","type":"company","lineage":["https://openalex.org/I4405268153"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Raymond Sanchez","raw_affiliation_strings":["Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, New Jersey, USA","institution_ids":["https://openalex.org/I4210086062","https://openalex.org/I4405268153"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108358185","display_name":"Robert D. McQuade","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086062","display_name":"Otsuka (United States)","ror":"https://ror.org/00ew4na22","country_code":"US","type":"company","lineage":["https://openalex.org/I114030911","https://openalex.org/I4210086062"]},{"id":"https://openalex.org/I4405268153","display_name":"Otsuka Pharmaceutical Development & Commercialization, Inc. (United States)","ror":"https://ror.org/001nxvg84","country_code":"US","type":"company","lineage":["https://openalex.org/I4405268153"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Robert D. McQuade","raw_affiliation_strings":["Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, New Jersey, USA","institution_ids":["https://openalex.org/I4210086062","https://openalex.org/I4405268153"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5110533970"],"corresponding_institution_ids":["https://openalex.org/I4210086062","https://openalex.org/I4405268153"],"apc_list":null,"apc_paid":null,"fwci":4.5146,"has_fulltext":false,"cited_by_count":77,"citation_normalized_percentile":{"value":0.95469662,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":99},"biblio":{"volume":"79","issue":"4","first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10854","display_name":"Bipolar Disorder and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/brexpiprazole","display_name":"brexpiprazole","score":0.9990000128746033},{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":0.9950000047683716},{"id":"https://openalex.org/keywords/adjunctive-therapy","display_name":"adjunctive therapy","score":0.8709999918937683},{"id":"https://openalex.org/keywords/antidepressant-refractory-depression","display_name":"antidepressant-refractory depression","score":0.7009999752044678},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.7870000004768372},{"id":"https://openalex.org/keywords/treatment-resistant-depression","display_name":"treatment-resistant depression","score":0.6830000281333923},{"id":"https://openalex.org/keywords/anxious-distress","display_name":"anxious distress","score":0.6100000143051147},{"id":"https://openalex.org/keywords/functional-disability","display_name":"functional disability","score":0.7129999995231628},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.7319999933242798},{"id":"https://openalex.org/keywords/fixed-dose-dosing","display_name":"fixed-dose dosing","score":0.628000020980835},{"id":"https://openalex.org/keywords/montgomery-asberg-depression-rating-scale","display_name":"Montgomery-Asberg Depression Rating Scale","score":0.7549999952316284},{"id":"https://openalex.org/keywords/sheehan-disability-scale","display_name":"Sheehan Disability Scale","score":0.9929999709129333},{"id":"https://openalex.org/keywords/outpatients","display_name":"outpatients","score":0.41100001335144043},{"id":"https://openalex.org/keywords/adults-with-depression","display_name":"adults with depression","score":0.5040000081062317},{"id":"https://openalex.org/keywords/inadequate-response-to-antidepressants","display_name":"inadequate response to antidepressants","score":0.6019999980926514}],"concepts":[{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8944263458251953},{"id":"https://openalex.org/C3018162438","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Adjunctive treatment","level":2,"score":0.6603413820266724},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6218506693840027},{"id":"https://openalex.org/C2780051608","wikidata":"https://www.wikidata.org/wiki/Q42844","display_name":"Major depressive disorder","level":3,"score":0.5565932989120483},{"id":"https://openalex.org/C204243189","wikidata":"https://www.wikidata.org/wiki/Q1363085","display_name":"Randomization","level":3,"score":0.4913441240787506},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.46939817070961},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4415161609649658},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4298091232776642},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.42884179949760437},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.3873315751552582},{"id":"https://openalex.org/C2779144063","wikidata":"https://www.wikidata.org/wiki/Q338924","display_name":"Amygdala","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001007","descriptor_name":"Anxiety","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D013876","descriptor_name":"Thiophenes","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013876","descriptor_name":"Thiophenes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015363","descriptor_name":"Quinolones","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D015363","descriptor_name":"Quinolones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.4088/jcp.17m12058","doi":"https://doi.org/10.4088/jcp.17m12058","is_oa":false,"landing_page_url":"https://doi.org/10.4088/jcp.17m12058","pdf_url":null,"source":{"id":"https://openalex.org/S17992710","display_name":"The Journal of Clinical Psychiatry","issn_l":"0160-6689","issn":["0160-6689","1534-8628","1555-2101"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4322614534","host_organization_name":"Physicians Postgraduate Press, Inc.","host_organization_lineage":["https://openalex.org/P4322614534"],"host_organization_lineage_names":["Physicians Postgraduate Press, Inc."],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Psychiatry","raw_type":"journal-article"},{"id":"pmid:29873953","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29873953","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical psychiatry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1868790909","https://openalex.org/W2789214860","https://openalex.org/W2140725933","https://openalex.org/W2957698583","https://openalex.org/W2911295141","https://openalex.org/W4414895110","https://openalex.org/W2891678680","https://openalex.org/W4403532512","https://openalex.org/W2565638269","https://openalex.org/W1979218784"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"assess":[2],"the":[3,72,94,107,175,195,235,241],"efficacy,":[4],"safety,":[5],"and":[6,23,106,121,209,243,254],"tolerability":[7,244],"of":[8,238,245],"brexpiprazole":[9,61,137,186,221,246],"as":[10,247],"adjunct":[11],"to":[12,26,33,53,58,77,118,132,147,200,234,257],"antidepressant":[13],"treatment":[14,249],"(ADT)":[15],"in":[16,80,96,109,194,250],"adults":[17],"with":[18,30,50,115,197,219,225,252],"major":[19],"depressive":[20,39],"disorder":[21],"(MDD)":[22],"inadequate":[24,31,51,255],"response":[25,32,52,117,199,256],"ADTs.":[27,258],"METHODS:":[28],"Outpatients":[29],"1-3":[34],"ADTs":[35],"during":[36],"their":[37],"current":[38],"episode":[40],"(DSM-IV-TR":[41],"criteria)":[42],"were":[43,56,93],"administered":[44],"prospective,":[45],"open-label":[46],"ADT.":[47],"Those":[48],"patients":[49,105,251],"prospective":[54,119,201],"ADT":[55,120,202],"randomized":[57],"double-blind,":[59],"adjunctive":[60,220,248],"2":[62],"mg/d":[63],"or":[64],"placebo.":[65],"The":[66,125],"primary":[67],"efficacy":[68,90,242],"end":[69,91],"point":[70],"was":[71,127,169,222],"change":[73,95,108],"from":[74,129,145],"baseline":[75,146],"(randomization)":[76],"week":[78,148],"6":[79,149],"Montgomery-\u00c5sberg":[81],"Depression":[82],"Rating":[83],"Scale":[84,99],"(MADRS)":[85],"total":[86,111,143,190],"score.":[87],"Key":[88],"secondary":[89],"points":[92],"Sheehan":[97],"Disability":[98],"(SDS)":[100],"mean":[101,157,177],"score":[102,112,144,178,191],"for":[103,113,174,240],"all":[104],"MADRS":[110,142,189],"subgroups":[114,196],"minimal":[116,198],"DSM-5-defined":[122],"anxious":[123,210],"distress.":[124],"study":[126,232],"conducted":[128],"July":[130],"2014":[131],"May":[133],"2016.":[134],"RESULTS:":[135],"Adjunctive":[136,185],"(n":[138,152],"=":[139,153,166,183,207,216],"191)":[140],"improved":[141,188],"versus":[150,192],"placebo":[151,193],"202;":[154],"least":[155],"squares":[156],"difference":[158],"[95%":[159],"confidence":[160],"limits]:":[161],"-2.30":[162],"[-3.97,":[163],"-0.62];":[164],"P":[165,182,206,215],".0074).":[167],"There":[168],"no":[170,226],"separation":[171],"between":[172],"groups":[173],"SDS":[176],"(-0.22":[179],"[-0.66,":[180],"0.23];":[181],".33).":[184],"also":[187],"(-2.25":[203],"[-4.23,":[204],"-0.27];":[205],".026)":[208],"distress":[211],"(-2.98":[212],"[-5.24,":[213],"-0.72];":[214],".0099).":[217],"Treatment":[218],"well":[223],"tolerated":[224],"unexpected":[227],"side":[228],"effects.":[229],"CONCLUSIONS:":[230],"This":[231],"adds":[233],"substantial":[236],"body":[237],"evidence":[239],"MDD":[253],"TRIAL":[259],"REGISTRATION:":[260],"ClinicalTrials.gov":[261],"identifier:":[262],"NCT02196506;":[263],"EudraCT":[264],"number:":[265],"2014-000062-22\u200b\u200b\u200b.":[266]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2803445534","counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":9},{"year":2024,"cited_by_count":12},{"year":2023,"cited_by_count":11},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":11},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":11},{"year":2018,"cited_by_count":5}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2018-06-01T00:00:00"}
